Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study

TIMP-1 Induces an EMT-Like Phenotypic Conversion in MDCK Cells Independent of Its MMP-Inhibitory Domain

(2012) Young Suk Jung et al.   PLoS One

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration

(2012) Douglas G. Altman et al.   PLOS MEDICINE

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Role of serum matrix metalloproteinase-2 and -9 to predict breast cancer progression

(2011) Suprava Patel et al.   CLINICAL BIOCHEMISTRY

Multiplexed Homogeneous Proximity Ligation Assays for High-throughput Protein Biomarker Research in Serological Material

(2011) Martin Lundberg et al.   MOLECULAR & CELLULAR PROTEOMICS

The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise

(2008) Susanne Møller et al.   ACTA ONCOLOGICA

Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer

(2008) Zheng-Sheng Wu et al.   INTERNATIONAL JOURNAL OF CANCER

A Comparative Study of Tissue Inhibitor of Metalloproteinases-1 Levels in Plasma and Tumour Tissue from Patients with Primary Breast Cancer and in Plasma from Patients with Metastatic Breast Cancer

(2008) Anne-Sofie Schrohl et al.   TUMOR BIOLOGY